United States Age Related Macular Degeneration Drug Market Report 2016

Publisher Name :
Date: 12-Sep-2016
No. of pages: 123

Notes:

Sales, means the sales volume of Age Related Macular Degeneration Drug

Revenue, means the sales value of Age Related Macular Degeneration Drug

This report studies sales (consumption) of Age Related Macular Degeneration Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Roche/Genentech

- Novartis

- Regeneron

- Bayer

- Valeant

- Allergan

- Alimera Sciences

- Ophthotech

- Acucela

- Ohr Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Age Related Macular Degeneration Drug in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Age Related Macular Degeneration Drug Market Report 2016

Table of Contents
United States Age Related Macular Degeneration Drug Market Report 2016
1 Age Related Macular Degeneration Drug Overview
1.1 Product Overview and Scope of Age Related Macular Degeneration Drug
1.2 Classification of Age Related Macular Degeneration Drug
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Age Related Macular Degeneration Drug
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Age Related Macular Degeneration Drug (2011-2021)
1.4.1 United States Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2021)
1.4.2 United States Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2021)
2 United States Age Related Macular Degeneration Drug Competition by Manufacturers
2.1 United States Age Related Macular Degeneration Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Age Related Macular Degeneration Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Age Related Macular Degeneration Drug Average Price by Manufactures (2015 and 2016)
2.4 Age Related Macular Degeneration Drug Market Competitive Situation and Trends
2.4.1 Age Related Macular Degeneration Drug Market Concentration Rate
2.4.2 Age Related Macular Degeneration Drug Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Age Related Macular Degeneration Drug Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Age Related Macular Degeneration Drug Sales and Market Share by Type (2011-2016)
3.2 United States Age Related Macular Degeneration Drug Revenue and Market Share by Type (2011-2016)
3.3 United States Age Related Macular Degeneration Drug Price by Type (2011-2016)
3.4 United States Age Related Macular Degeneration Drug Sales Growth Rate by Type (2011-2016)
4 United States Age Related Macular Degeneration Drug Sales (Volume) by Application (2011-2016)
4.1 United States Age Related Macular Degeneration Drug Sales and Market Share by Application (2011-2016)
4.2 United States Age Related Macular Degeneration Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Age Related Macular Degeneration Drug Manufacturers Profiles/Analysis
5.1 Roche/Genentech
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Roche/Genentech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Novartis
5.2.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Regeneron
5.3.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Regeneron Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Bayer
5.4.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Bayer Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Valeant
5.5.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Valeant Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Allergan
5.6.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Allergan Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Alimera Sciences
5.7.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Alimera Sciences Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Ophthotech
5.8.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Ophthotech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Acucela
5.9.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Acucela Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Ohr Pharmaceuticals
5.10.2 Age Related Macular Degeneration Drug Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Ohr Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
6 Age Related Macular Degeneration Drug Manufacturing Cost Analysis
6.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Age Related Macular Degeneration Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Age Related Macular Degeneration Drug Market Forecast (2016-2021)
10.1 United States Age Related Macular Degeneration Drug Sales, Revenue Forecast (2016-2021)
10.2 United States Age Related Macular Degeneration Drug Sales Forecast by Type (2016-2021)
10.3 United States Age Related Macular Degeneration Drug Sales Forecast by Application (2016-2021)
10.4 Age Related Macular Degeneration Drug Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Age Related Macular Degeneration Drug
Table Classification of Age Related Macular Degeneration Drug
Figure United States Sales Market Share of Age Related Macular Degeneration Drug by Type in 2015
Table Application of Age Related Macular Degeneration Drug
Figure United States Sales Market Share of Age Related Macular Degeneration Drug by Application in 2015
Figure United States Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2021)
Figure United States Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2021)
Table United States Age Related Macular Degeneration Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Age Related Macular Degeneration Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Age Related Macular Degeneration Drug Sales Share by Manufacturers
Figure 2016 Age Related Macular Degeneration Drug Sales Share by Manufacturers
Table United States Age Related Macular Degeneration Drug Revenue by Manufacturers (2015 and 2016)
Table United States Age Related Macular Degeneration Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Age Related Macular Degeneration Drug Revenue Share by Manufacturers
Table 2016 United States Age Related Macular Degeneration Drug Revenue Share by Manufacturers
Table United States Market Age Related Macular Degeneration Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Age Related Macular Degeneration Drug Average Price of Key Manufacturers in 2015
Figure Age Related Macular Degeneration Drug Market Share of Top 3 Manufacturers
Figure Age Related Macular Degeneration Drug Market Share of Top 5 Manufacturers
Table United States Age Related Macular Degeneration Drug Sales by Type (2011-2016)
Table United States Age Related Macular Degeneration Drug Sales Share by Type (2011-2016)
Figure United States Age Related Macular Degeneration Drug Sales Market Share by Type in 2015
Table United States Age Related Macular Degeneration Drug Revenue and Market Share by Type (2011-2016)
Table United States Age Related Macular Degeneration Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Age Related Macular Degeneration Drug by Type (2011-2016)
Table United States Age Related Macular Degeneration Drug Price by Type (2011-2016)
Figure United States Age Related Macular Degeneration Drug Sales Growth Rate by Type (2011-2016)
Table United States Age Related Macular Degeneration Drug Sales by Application (2011-2016)
Table United States Age Related Macular Degeneration Drug Sales Market Share by Application (2011-2016)
Figure United States Age Related Macular Degeneration Drug Sales Market Share by Application in 2015
Table United States Age Related Macular Degeneration Drug Sales Growth Rate by Application (2011-2016)
Figure United States Age Related Macular Degeneration Drug Sales Growth Rate by Application (2011-2016)
Table Roche/Genentech Basic Information List
Table Roche/Genentech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche/Genentech Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Regeneron Basic Information List
Table Regeneron Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Regeneron Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Valeant Basic Information List
Table Valeant Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Alimera Sciences Basic Information List
Table Alimera Sciences Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alimera Sciences Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Ophthotech Basic Information List
Table Ophthotech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ophthotech Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Acucela Basic Information List
Table Acucela Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Acucela Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Ohr Pharmaceuticals Basic Information List
Table Ohr Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ohr Pharmaceuticals Age Related Macular Degeneration Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Age Related Macular Degeneration Drug
Figure Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure Age Related Macular Degeneration Drug Industrial Chain Analysis
Table Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015
Table Major Buyers of Age Related Macular Degeneration Drug
Table Distributors/Traders List
Figure United States Age Related Macular Degeneration Drug Production and Growth Rate Forecast (2016-2021)
Figure United States Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2016-2021)
Table United States Age Related Macular Degeneration Drug Production Forecast by Type (2016-2021)
Table United States Age Related Macular Degeneration Drug Consumption Forecast by Application (2016-2021)
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • United States Atropine Market Report 2017
    Published: 28-Feb-2017        Price: US 3800 Onwards        Pages: 95
    Notes: Sales, means the sales volume of Atropine Revenue, means the sales value of Atropine This report studies sales (consumption) of Atropine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Minsheng Pharmaceutical - Sunrise Nutrachem - Henan PURUI Pharmaceutical - CR Double-Crane Pharmaceuticals - Guangzhou Hanfang Pharmaceutical - Arshine -......
  • United States Pycnogenol Market Report 2017
    Published: 28-Feb-2017        Price: US 3800 Onwards        Pages: 122
    Notes: Sales, means the sales volume of Pycnogenol Revenue, means the sales value of Pycnogenol This report studies sales (consumption) of Pycnogenol in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Horphag Research Inc - Superior Supplement Manufacturing - Sun Pharmaceuticals - Alkem Laboratories - Ochoa Laboratories - Amlin Health Llc - Scele......
  • United States Ampicillin Capsules Market Report 2017
    Published: 28-Feb-2017        Price: US 3800 Onwards        Pages: 100
    Notes: Sales, means the sales volume of Ampicillin Capsules Revenue, means the sales value of Ampicillin Capsules This report studies sales (consumption) of Ampicillin Capsules in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - DSM - ACS Dobfar - Kopran - Antibioticos - United Laboratories - Shandong Lukang Pharmaceutical - CSPC Pharmaceutical......
  • Global Dental Bridges Market Research Report 2017
    Published: 28-Feb-2017        Price: US 2900 Onwards        Pages: 122
    Notes: Production, means the output of Dental Bridges Revenue, means the sales value of Dental Bridges This report studies Dental Bridges in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Densply - Danaher - Modern?Dental - Ivoclar Vivadent - 3M......
  • Global Dental Prosthetics Market Research Report 2017
    Published: 28-Feb-2017        Price: US 2900 Onwards        Pages: 125
    Notes: Production, means the output of Dental Prosthetics Revenue, means the sales value of Dental Prosthetics This report studies Dental Prosthetics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Densply - Ivoclar Vivadent - Nobel Biocare - Straumann......
  • Global Erbitux Market Research Report 2017
    Published: 28-Feb-2017        Price: US 2900 Onwards        Pages: 103
    In this report, the global Erbitux market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Erbitux in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan - Sout......
  • United States a-bisabolol Market Report 2017
    Published: 28-Feb-2017        Price: US 3800 Onwards        Pages: 111
    Notes: Sales, means the sales volume of a-bisabolol Revenue, means the sales value of a-bisabolol This report studies sales (consumption) of a-bisabolol in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Atina - BASF Care Creations - Beijing Brilliance Bio - Biocosmethic - DKSH North America, Inc. - EMD Chemicals Inc. / Rona - Extracts & Ingredie......
  • United States Decitabine Market Report 2017
    Published: 28-Feb-2017        Price: US 3800 Onwards        Pages: 111
    Notes: Sales, means the sales volume of Decitabine Revenue, means the sales value of Decitabine This report studies sales (consumption) of Decitabine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Xingcheng Chempharm Co.,Ltd. - Fresenius Kabi Oncology Limited - Melone Pharmaceutical Co., Ltd - Natco Pharma - Shilpa Medicare - Hotai Pharmaceutical Co......
  • United States Phosphodiesterase Inhibitor Market Report 2017
    Published: 28-Feb-2017        Price: US 3800 Onwards        Pages: 95
    Notes: Sales, means the sales volume of Phosphodiesterase Inhibitor Revenue, means the sales value of Phosphodiesterase Inhibitor This report studies sales (consumption) of Phosphodiesterase Inhibitor in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Actelion Pharmaceuticals - United Therapeutics Corporation - Gilead sciences - Bayer AG - SteadyMed - G......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs